Finding the right dose: nerve block study aims to cut opioid use after Weight-Loss surgery

NCT ID NCT07510347

Recruiting now Symptom relief Sponsor: Menoufia University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares three volumes of a nerve block (M-TAPA) to see which provides the best pain relief after laparoscopic sleeve gastrectomy. Sixty adults undergoing this weight-loss surgery will receive one of three volumes of bupivacaine. The goal is to find the optimal volume that delays the need for additional pain medication and reduces opioid use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bupivacaine
What this could lead to: If successful, this could identify the best volume of local anesthetic for pain relief after sleeve gastrectomy, reducing opioid use and improving recovery.
What could go wrong: This is a small, early-phase trial with only 60 participants, so results may not apply to all patients. The nerve block may not provide better pain control than standard methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TIME

Contacts and locations

Locations

Menofia faculty of medicine
RECRUITING

Shibīn al Kawm, Menofia, 32511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.